Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Compositional models for mortality by age, sex and cause, Joshua A Salomon; 2. The epidemiological transitional: policy and planning implications for developing countries, James N. Gribble; 3. Methodology for measuring health-state preferences - 1: measurement strategies, Debra G. Froberg; 4. Methodology for measuring health-State preferences - II: scaling methods, Debra G. Froberg; 5. Methodology for measuring health-State preferences - III: population and context effects, Debra G. Froberg; 5. Measurement of health state utilities for economic appraisal : a review, George W. Torrance; 7. Methods for quality adjusment of life years, Erik Nord; 8. The person-trade-off approach to valuing health care programs, Erik Nord; 9. Cost utility analysis: what should be measured?, J. Richardson; 10. Health state valuations from the general public using the visual analogue scale, C Gudex; 11. Modeling valuations for EuroQol health states, Paul Dolan; 12. Deriving preference-based single index from the UK SF-36 health survey, John Brazier; 13. Measuring preferences for health states worse than death, Donald L. Patrick; 14. Multiattribute utility function for a comprehensive health status classification system health utilities index mark 2, George W. Torrance; 15. Evaluating healthy days of life gained from health projects, Howard Barnum; 16. The utility of health at different stages in life: a quantitative approach, Jan J. V.B; 17. The economic cost of illness revisited, Barbara S. Cooper; 18. Is the valuation of a qaly gained independent of age? some empirical evidence, Magnus J; 19. Discounting in the economic evaluation of health care interventions, Murray K; 20. Maximizing health benefits vs egalitarianism: an Australian survey of health issues, Erik N; 21. Estimating the cost of illness, Dorothy P.R.; 22. Discounting in health care decision-making: time for a change ?, Trevor A. Sheldon; 23. Discounting the future: influence of the economic model, Robert R. West; 24. Penn world tables 5.6, Alan H; 25. On the comparable quantification of health risks: lessons from the global burden of disease study, Christophr J.L.M; 26. Conceptual problems in the definition and interprtation of attributable fractions, Sander G; 27. Estimability and estimation of excess and etiologic fractions, James M. Robin; 28. Reducing the global burden of blood pressure-related cardiovascular disease, Anthony R; 29. The Australian burden of disease study: measuring the loss of health from diseses, injuries and risk factors, Colin DM; 30. Mortality in relation to smoking: 40 years' observations on male British doctors, Richard D; 31. Estimated numbers of deaths from coronary heart disease "Caused" and "prevented" by alcohol: an example from Finland, Pia M; 32. Mortality from tobacco in developed countries: indirect estimation from national vital statistics, Richard P.A; 33. Intake of fatty acids and risk of coronary heart disease in a cohort of finnish men, Pirjo Pietinen; 34. Alcohol consumption and mortality among middle-aged and elderly U.S. adults, Michael J. Thun; 35. An improved aetiologic fraction of alcohol caused morbidity and mortality; 36. Dietary fat intake and the risk of coronary heart disease in women, Frank B. Hu; 37. Obesity, mortality and cardiovascular disease in the munster heart study (PROCAM), Helmut S; 38. The burden of dsease in Mexico in 1994: advances and challenges, Rafael Lozano; 39. The burden of disease and injury in Australia, Colin Mathers)
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding
Workshop on eviden for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Model of mortality and age composition; 2. Life tables for 191 countries: data methods and results, A.D. Lopez (et al); 3. WHO system of model life tables, C.J.L. Murray (et al); 4. Measuring mortality, fertility, and natural increase: a self teaching guide elementary measures, James A. Palmore; 5. MortPak-life: the United Nations software package for mortality measurement; 6. Measuring the health of the U.S. population, David M. Cutler; 7. Summarizing population health: directions for the development and application of population metrics; 8. A critical examination of summary measures of population health, Christopher J.L. Murray (et al); 9. Health status assessment methods for adults: past accomplishments and future challenges, Colleen A. McHorney; 10. Comparative analysis more than 50 household surveys on health status, Ritu Sadana (et al); 11. Health expectancy: an indicator for change ?, Jan J. Barendregt (et al); 12. Health expectancies: an overview and critical appraisal, Colin Mathers; 13. Estimates of dale for 191 countries: methods and results, Colin D. Mathers (et al); 14. Active life among the elderly in the United States: multistate life-table estimates and population projections, Richard G. Rogers; 15. Premature mortality in the United States: public health issues in the use of years of potential life lost; 16. Decline in tuberculosis: the death rate falls to tell entire story, Mary Dempsey; 17. Aging, natural death, and the compression of morbidity, James F. Fries; 18. A standardized rate for mortality defined in units of lost years of life, William Haenszel; 18. Measuring the burden of disease: healthy life-years, Adnan A. Hyder; 19. Applying burden of disease methods in developing countries: a case study from Pakistan, Adnan A Hyder; 20. Past and future life expectancy increases at later ages: thrie implications for the linkage of chronic morbidity, disability, and mortality, Kenneth G. Manton; 21. Premature death in the United States: years of life lost and health priorities, Janet D. Perloff (et al); 22. Use of direct and indirect techniques for estimating the completeness of death registration systems, Samuel H. Preston; 23. Approaches to the collection of mortality data in the context of data needs; 24. Age patterns of marriage, Ansley J. Coale; 25. Factors influincing discrepancies between premortem and postmortem diagnoses, Ron M. Battle (et al); 26. Diagnostic errors discovered at autopsy, Mona Britton; 27. Verbal autopsies for adult deaths: issues in their development and validation, Daniel C. (et al); 28. Elements for a theory of the health transition, Julio F. (et al); 29. Analytical potential for multiple cause-of-death data, Robert A. Israel; 30. Death certificate coding practices related to diabetes in European countries - the 'EURODIAB subarea C' study, Eric J. (et al); 31. The Epidemiologic transition: a theory of the epidemiology of population change, Abdel R. Omran; 32. Childhood deaths in Africa: use and limitations of verbal autopsies; 33. Maternal recall of symptoms associated with childhood deaths in rural East Africa, RW Snow, (et al); 34. An appraisal of the epidemic rise of coronary heart disease and its decline, W.E. stehbens; 35. Measurement of overall and causes-specific mortality in infants and children: memorandum from a WHO/UNICEF meeting)
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding
Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems: 1. Health expectancy: from a population health indicator to a tool for policy making; A single index of mortality and morbidity; 3. POlicy relevance of the health expectancy indicator; an inventory in European Union countries; 4. Health expectancy in Canada, Late 1970s: Demographic, regional, and social dimensions; 5. Adjusting life expectancy to account for disability in a population: a comparison of three techniques; 6. Health-life expectancy according to various functional levels; 7. Health inequality concepts: The relationship between socioeconomic status and health: a review of the literature; 8. Defining and measuring health inequality: an approach based on the distribution of health expectancy; 9. Health inequalities and the health of the poor: what do we know ? what can we do ?; 10. Sociodemographic differentials in adult mortality: a review of analytic approaches; 11. Income inequality and population health; 12. Making the most of statistical analysis: improving interpretation and presentation; 13. International variation in socioeconomic inequalities in self reported health; 14. Health inequalities and social group differences: what should we measure ?; 15. The extended beta binomial model in political analysis; 16. Problem in the measurement and international comparisons of socio-economic differences in mortality; 17. Income-related inequalities in health: some international comparisons; 18. Socioeconomic inequalities in child mortality: comparisons across nine developing countries; 19. The concepts and principles of equity and health; 20. Socioeconomic determinants of health: health inequalities: relative or absolute material standards ?; 21. A framework for measuring responsiveness; 22. Patient satisfaction: a review of issues and concepts; 23. Expectations as determinants of patient satisfaction: concepts, theory and evidence; 24. The meaning of patient satisfaction: an explanation of high reported levels; 25. Principles of the system of health accounts; 26. Estimates of national health accounts (NHA) for 1997: GPE discussion paper series: No.27 ; 27. A system of health statistics toward a new conceptual framework for integrating health data; 28. Macroeconomic theory and policy; 29. Permanent household income and consumption in urban South America; 30. Economics of the public sector; 31. Household health expenditures in Nepal: implications for health care financing reform; 32. Equity in the finance of health care: some further international comparisons; 33. Equity in the finance and delivery of health care: an international perspective; 34. Structured pluralism: towards an innovative model for health system reform in Latin America; 35. Health sector development: from aid coordination to resource management; 36. The health care quadrilemma: an essay on technological change insurance, quality of care, and cost containment; 37. National health accounts in developing countries: appropriate methods and recent applications; 38. Proposals for a homogeneous treatment of health expenditures in the national accounts; 39. State health expenditure accounts: building blocks for state health spending analysis; 40.
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding
Workshop on evidence for health policy: burden of disease, Cost-Effectiveness, and health systems (Daftar isi: 1.Expanding the WHO tuberculosis control strategy: rethinking the role active case-finding, C.J.L. Murray; 2. Modeling the impact of global tuberculosis control strategies, ChristopherJ.L. Murray; 3. The decision rules of cost-effectiveness analysis, Goran Karlsson; 4. On the decision relus of cost-effectiveness analysis, Magnus Johannesson; 5. Cost-effectiveness and capital costs, Goran k; 6. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations, Andreas Laupacis; 7. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 8. Cost-effectiveness and cost-benefit analysis of health services: the methodology and its application, A. Griffiths; 9. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, Frank A. Sloan; 10. Cost-benefit analysis (CBA); 11. Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature, Karen B; 12. The use of conjoint analysis to elicit willingness-to-pay values: proceed with caution?, Julie Ratcliffe; 13. Is there a role for benefit-cost analysis in environmental, health, and safety regulation ?, Kenneth J. Arrow; 14. Reasons and persons, Derek Parfit; 15. Qalys and ethics: a health economist's perspective, Alan Williams; 16. Double jeopardy and the use of QALYs in health care allocation, Peter Singer; 17. Double jeopardy, the equal value of lives and the veil of ignorance: a rejoinder to harris, John McKie; 18. The value of DALY life: problems with ethics and validity of disability adjusted life years, Erik Nord; 19. Public preferences for the allocation of donor liver grafts for transplantation, Julie Ratclife; 20. Distributing scarce livers: the moral reasoning of the general public, Peter A. Ubel; 21. Recognizing bedside rationing: clear cases and tough calls, Peter A. Ubel; 22. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial, Mohammad A. Chaudhary; 23. Reflecting uncertainty in cost-effectiveness analysis, W.G. Manning; 24. Hanling uncertanty in economic evaluation, Andrew Briggs; 25. Probabilistic sensitivity analysis in cost-effectiveness: an application from a study of vaccination against pneumococcal bacteremia in the elderly, William Whang; 26. Estimating uncertainty ranges for cost by the bootstrap procedure combined with probabilistic sensitivity analysis, Joanne Lord; 27. Uncertaintyin the economic evaluation of health care technologies: the role of sensitivity analysis, Andrew Briggs; 28. Building uncertainty into cost-effectiveness rankings portofolio risk-return tradeoffs and implications for decision rules, Bernie J. O'Brien; 29. Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania, Eric De Jonghe; 30. Linking measures of health gain to explicit priority setting by an area health service in Australia, David A Cromwell; 31. Using discrete choice modelling in priority setting: an application to clinical service developments, Shelley Farrar; 32. Cost-effectiveness analysis and policy choices: investing in health systems, C.J.L. Murray; 33. A cost-effectiveness model for allocating health sector resources, Christopher Murray; 34. Disease control priorities in developing countries: an overview, Dean T. Jamison; 35. Oregon's medicaid ranking and cost-effectiveness: is there any relationship ?, Tammy O. Tengs; 36. Five-hundred life-saving interventions and their cost-effectiveness, Tammy O. Tengs; 37. Prioritising health services in an era of limits: the Oregon experience, John A Kitzhaber; 38. Priority setting: lessons from Oregon, Jennifer Dixon; 39. Oregon's methods: did cost-effectiveness analysis fail?; 40.
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding
Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems: 1. Responsiveness measures: consumer assessment of health plans study (CAHPS TM); 2. The use of cognitive testing to develop and evaluate CAHPS TM 1.0 core survey items; 3. Psychometric properties of the CAHPS TM 1.0 survey measures; 4. WHO strategy on measuring responsiveness; 5. Measuring responsiveness: results of a key informants survey in 35 countries; 6. WHO survey on health and health system responsiveness: questionnaire sections - draft; 7. Health system responsiveness survey : draft questionnaire - responsiveness section only; 8. Surveying health system preferences: Measuring preferences on health system performance assessment; 9. Overall goal attainment: Human development index: methodology and mmeasurement; 10. Good and bad growth: the human development reports; 11. Overall performance concepts: The comparative efficiency of national health systems in producing health: an analysis of 191 countries; 12. Frontier production functions and technical efficiency measures; 13. The estimation of technical efficiency; 14. Production frontiers and panel data; 15. Overall performance measures: The efficiency of government expenditure: experiences from Africa; 16. Measuring health production performance in the OECD; 17. What do the human development indices reveal?; 18. Exercise on measuring preferences: Health financing: Uncertainty and the welfare economics of medical care; 19. Incentives and provider payment methods; 20. Health insurance schemes for people outside formal sector employment; 21. New Zealand's health reforms: a clash of culture; 22. Improving allocative efficiency of health interventions: searching for policy tools; 23. Public and private roles in health: theory and financing patterns; 24. Some interim results from a controlled trial of cost sharing in health insurance; 25. Primary care reform: a country comparison of 'budget holding'; 26. Provision: Design, content and financing of an essential national package of health services; 27. The history and pronciples of managed competition; 28. Limits to rationality: economics, economists and priority setting; 29. Sub-National application of health systems performance framework: Measuring overall health system performance for 191 countries; 30.
[s.l.] : Geneva: WHO, 2000, s.a.]
Prosiding
Cost-effectiveness in health and medicine
[s.l.] : [s.n.] : s.a.]
Buku (pinjaman 1 minggu)
Perencanaan kesehatan untuk meningkatkan efektifitas manajemen
editor, William A. Reinke; diterjemahkan oleh Laksono Trisnantoro, Sigit Ryanto; penyunting, Mubasyir Hasanbasri, Titi Savitri
Yogyakarta : Gadjah Mada University Press, 1994
Buku (pinjaman 1 minggu)
Zero base budgeting for health care institutions
Ray D. Dillon
Maryland : Aspen Systems Corporation, 1979
Buku (pinjaman 1 minggu)
Benefits and costs of alternative health care waste management: an example of the largest hospital of Nepal
[s.l.] : [s.n.] : s.a.]
Indeks Artikel Jurnal-Majalah
Analisis biaya dan manfaat = Cost and benefit analysis
Radiks Purba
Jakarta : Rineka Cipta, 1997
Buku (pinjaman 1 minggu)